RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 66 filers reported holding RECRO PHARMA INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $352,000 | +3.2% | 38,000 | 0.0% | 0.03% | -52.8% |
Q3 2017 | $341,000 | +27.7% | 38,000 | 0.0% | 0.07% | +9.1% |
Q2 2017 | $267,000 | -53.4% | 38,000 | -42.0% | 0.07% | -61.4% |
Q1 2017 | $573,000 | -6.5% | 65,550 | -13.8% | 0.17% | -65.0% |
Q4 2016 | $613,000 | -3.6% | 76,000 | +5.6% | 0.49% | +97.2% |
Q3 2016 | $636,000 | – | 72,000 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MAK CAPITAL ONE LLC | 850,129 | $2,423,000 | 0.65% |
Newtyn Management, LLC | 700,000 | $1,995,000 | 0.46% |
Portolan Capital Management | 1,293,376 | $3,686,000 | 0.34% |
Rubric Capital Management LP | 1,076,587 | $3,068,000 | 0.22% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 99,046 | $282,000 | 0.04% |
Alyeska Investment Group, L.P. | 736,821 | $2,100,000 | 0.03% |
STEPHENS INC /AR/ | 510,569 | $1,455,000 | 0.03% |
Clear Harbor Asset Management, LLC | 46,682 | $133,000 | 0.02% |
WYNNEFIELD CAPITAL INC | 13,000 | $37,000 | 0.02% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 451,301 | $1,286,000 | 0.01% |